Notificação de entrada na fase nacional - PCT
#1.3
06/11/2024
RPI 2788
Application data
Number
112024004678Type
Filing
Publication
PCT
US2022076393 The application was filed at the INPI on 09/14/2022. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 06/11/2024. We update with every new RPI gazette, published weekly.
Applicants
VANDA PHARMACEUTICALS INC.
US
Inventors
C. P. (pessoa física)
US
M. P. (pessoa física)
US
S. S. (pessoa física)
US
IPC Classification
Priority claims
US
63/243,918 · 09/14/2021
US
63/268,430 · 02/23/2022
US
63/269,137 · 03/10/2022
Abstract
A invenção se refere, em geral, ao tratamento de transtorno do espectro autista (TEA) e distúrbios do sono e, mais particularmente, ao tratamento de distúrbios do sono e/ou à melhora do funcionamento diurno em pacientes com TEA usando tasimelteon.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
06/11/2024
RPI 2788
#1.1
03/19/2024
RPI 2776
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.